Molecular forms of the insulin-like growth factor-binding protein-2 in patients with colorectal cancer.

No abstract is available for this paper.

• Publication year

  2014

• Venue

  Experimental and molecular pathology (Print)

• Publication date

  2014-02-01

• Fields of study

  Biology, Medicine, Chemistry

• Identifiers
  DOI 10.1016/j.yexmp.2013.11.006PMID 24275430
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interaction of Insulin-Like Growth Factor-Binding Protein 2 with α2-Macroglobulin in the Circulation

  2013cited by this paper
• Protein carbonyl levels, glutathione S-transferase polymorphisms and risk of colorectal cancer.

  2010cited by this paper
• Oxidative stress, inflammation, and cancer: how are they linked?

  2010cited by this paper
• Plasma insulin-like growth factor-binding protein-2 levels as diagnostic and prognostic biomarker of colorectal cancer.

  2010cited by this paper
• Integrin Structure and Function

  2010cited by this paper
• Determination the Sialic Acid in Colorectal Cancer and its Correlation to Some Enzymes

  2009cited by this paper
• Interaction of Insulin-like Growth Factor-binding Protein-3 and BAX in Mitochondria Promotes Male Germ Cell Apoptosis

  2009cited by this paper
• Insulin-Like Growth Factor Binding Protein-2 Is a Novel Therapeutic Target Associated with Breast Cancer

  2008cited by this paper
• Plasma glycoprotein profiling for colorectal cancer biomarker identification by lectin glycoarray and lectin blot.

  2008cited by this paper
• Matrix metalloproteinase‐7 triggers the matricrine action of insulin‐like growth factor‐II via proteinase activity on insulin‐like growth factor binding protein 2 in the extracellular matrix

  2007influential reference
• Altered Glycosylation in Cancer: Sialic Acids and Sialyltransferases

  2005cited by this paper
• Significant expression of IGFBP2 in breast cancer compared with benign lesions

  2005cited by this paper
• Integrin-mediated action of insulin-like growth factor binding protein-2 in tumor cells.

  2004cited by this paper
• Bimolecular Interaction of Insulin-Like Growth Factor (IGF) Binding Protein-2 with αvβ3 Negatively Modulates IGF-I-Mediated Migration and Tumor Growth 1

  2004cited by this paper
• IIp45, an insulin-like growth factor binding protein 2 (IGFBP-2) binding protein, antagonizes IGFBP-2 stimulation of glioma cell invasion

  2003cited by this paper
• The insulin-like growth factor system.

  2003cited by this paper
• The Insulin-Like Growth Factor System

  2003cited by this paper
• Matrilysin (MMP-7) induces homotypic adhesion of human colon cancer cells and enhances their metastatic potential in nude mouse model

  2003cited by this paper
• Insulin-like growth factor binding protein 2 enhances glioblastoma invasion by activating invasion-enhancing genes.

  2003cited by this paper
• Cellular actions of the insulin-like growth factor binding proteins.

  2002cited by this paper
• Insulin-like growth factor-binding protein 2 in tumorigenesis: protector or promoter?

  2001cited by this paper
• α2-Macroglobulin: a New Component in the Insulin-like Growth Factor/Insulin-like Growth Factor Binding Protein-1 Axis*

  2001cited by this paper
• QUANTIFICATION AND SIGNIFICANCE OF PROTEIN OXIDATION IN BIOLOGICAL SAMPLES*

  2000cited by this paper
• Protein Oxidation

  2000cited by this paper
• Role of insulin‐like growth factors and their binding proteins in growth control and carcinogenesis

  2000cited by this paper
• Reactivation of insulin-like growth factor binding protein 2 expression in glioblastoma multiforme: a revelation by parallel gene expression profiling.

  1999cited by this paper
• Determination of protein carbonyl groups by immunoblotting.

  1999influential reference
• Response: More About: Prospective Study of Colorectal Cancer Risk in Men and Plasma Levels of Insulin-Like Growth Factor (IGF)-I and IGF- Binding Protein-3

  1999cited by this paper
• Prospective study of colorectal cancer risk in men and plasma levels of insulin-like growth factor (IGF)-I and IGF-binding protein-3.

  1999cited by this paper
• Insulin-like growth factors and their binding proteins in human colonocytes: preferential degradation of insulin-like growth factor binding protein 2 in colonic cancers.

  1997cited by this paper
• Insulin-like growth factor-binding proteins in serum and other biological fluids: regulation and functions.

  1997cited by this paper
• Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor.

  1997cited by this paper
• Distribution of insulin/insulin-like growth factor-I hybrid receptors in human tissues.

  1997cited by this paper
• The role of the insulin-like growth factor binding proteins and the IGFBP proteases in modulating IGF action.

  1996cited by this paper
• Expression of IGF-I and IGF-binding protein genes in cirrhotic liver.

  1996cited by this paper
• Serum levels of insulin-like growth factor-I,-II and insulin-like growth factor binding proteins-2 and-3 in children with acute lymphoblastic leukaemia

  1996cited by this paper
• Alterations in serum levels of insulin‐like growth factors and insulin‐like growth‐factor‐binding proteins in patients with colorectal cancer

  1994influential reference
• Insulin-like growth factor-I (IGF-I) and IGF-binding protein-2 are increased in cyst fluids of epithelial ovarian cancer.

  1994cited by this paper
• Binding of IL-1 beta to alpha-macroglobulins and release by thioredoxin.

  1990cited by this paper
• Determination of carbonyl content in oxidatively modified proteins.

  1990cited by this paper
• The binding of insulin and somatomedin A to human placental membrane.

  1975cited by this paper

• Plasma biomarkers in patients with age-related sarcopenia: a proteomic exploration and experimental validation

  2024cites this paper
• Diagnostic Accuracy of a Blood-Based Biomarker Panel for Colorectal Cancer Detection: A Pilot Study

  2024cites this paper
• The Insulin-like Growth Factor System and Colorectal Cancer

  2022cites this paper
• IGFBP2 in cancer: Pathological role and clinical significance (Review).

  2020cites this paper
• Expression of genes encoding IGF1, IGF2, and IGFBPs in blood of obese adolescents with insulin resistance

  2019cites this paper
• Oral Administration of Microencapsulated B. Longum BAA-999 and Lycopene Modulates IGF-1/IGF-1R/IGFBP3 Protein Expressions in a Colorectal Murine Model

  2019cites this paper
• IGFBP2 promotes the EMT of colorectal cancer cells by regulating E-cadherin expression.

  2019cites this paper
• IGF-binding protein 2 is a candidate target of therapeutic potential in cancer

  2016cites this paper
• Insulin-Like Growth Factor 2 - The Oncogene and its Accomplices.

  2016cites this paper
• Insulin-Like Growth Factor II mRNA-Binding Protein 3 (IMP3) as a Useful Immunohistochemical Marker for the Diagnosis of Adenocarcinoma of Small Intestine

  2015cites this paper
• Identification of differentially expressed serum proteins in gastric adenocarcinoma.

  2015cites this paper
• Blood-Based Protein Biomarker Panel for the Detection of Colorectal Cancer

  2015cites this paper
• Expression and underlying roles of IGFBP-3 in paclitaxel-treated gastric cancer SGC-7901 cells.

  2014cites this paper